MANGALAM

Mangalam Drugs And Organics Share PriceMangalam Drugs and Organics

₹99.5
2.9 (3%)
As on 07 December, 2023 | 03:01 BSE: 532637 NSE: MANGALAMISIN: INE584F01014

Mangalam Drugs And Organics Performance

Day Range

  • Low 96.00
  • High 102.00
₹ 99.5

52 Week Range

  • Low 93.80
  • High 145.45
₹ 99.5
  • Open Price96.60
  • Previous Close96.60
  • Volume181093

Start SIP in Mangalam Drugs and Organics

Start SIP

Mangalam Drugs And Organics Share Price

  • Over 1 Month -1.68%
  • Over 3 Month -5.55%
  • Over 6 Month -5.06%
  • Over 1 Year -27.85%

Mangalam Drugs And Organics Key Statistics

P/E Ratio -9.2
PEG Ratio 0
Market Cap Cr 158
Price to Book Ratio 1
EPS 0.8
Dividend 0
Relative Strength Index 52.54
Money Flow Index 45.53
MACD Signal -1.15
Average True Range 3.06

Mangalam Drugs And Organics Investment Rating

  • Master Rating:
  • Mangalam Drugs & Orgs. has an operating revenue of Rs. 323.46 Cr. on a trailing 12-month basis. An annual revenue de-growth of -17% needs improvement, Pre-tax margin of 1% needs improvement, ROE of 0% is poor and needs improvement. The company has a reasonable debt to equity of 12%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 8 which is a POOR score indicating inconsistency in earnings, a RS Rating of 9 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D which indicates heavy supply, Group Rank of 65 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Mangalam Drugs and Organics Financials
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 82879063108109120
Operating Expenses Qtr Cr 7991915710099111
Operating Profit Qtr Cr 2-30681010
Depreciation Qtr Cr 4333333
Interest Qtr Cr 3333343
Tax Qtr Cr -1-1-1011-2
Net Profit Qtr Cr -4-10-40237
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 373451
Operating Expenses Annual Cr 347402
Operating Profit Annual in Cr 2649
Depreciation Cr 1110
Interest Annual Cr 1311
Tax Annual Cr 18
Net Profit Annual Cr 120
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 26
Cash from Investing Activity Annual Cr -27
Cash from Financing Annual Activity Cr 3
Net Cash Flow Annual Cr 1
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 152151
Fixed Assets Annual Cr 132141
Total Non Current Assets Annual Cr 153146
Total Current Assets Annual Cr 207182
Total Assets Annual Cr 360328
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 9695
ROE Annual % 113
ROCE Annual % 820
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 711
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 533
Operating Expenses Annual Cr 512
Operating Profit Annual in Cr 11
Depreciation Cr 1
Interest Annual Cr 2
Tax Annual Cr 6
Net Profit Annual Cr 12
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 2
Cash from Investing Activity Annual Cr -40
Cash from Financing Annual Activity Cr 42
Net Cash Flow Annual Cr 4
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 45
Fixed Assets Annual Cr 50
Total Non Current Assets Annual Cr 57
Total Current Assets Annual Cr 65
Total Assets Annual Cr 123
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 25
ROE Annual % 27
ROCE Annual % 40
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 4

Mangalam Drugs And Organics Technicals

EMA & SMA

Current Price
₹99.5
2.9 (3%)
pointer
  • Bullish Moving Average
  • ___
  • 9
  • Bearish Moving Average
  • ___
  • 7
  • 20 Day
  • ₹98.31
  • 50 Day
  • ₹100.21
  • 100 Day
  • ₹102.83
  • 200 Day
  • ₹108.17
  • 20 Day
  • ₹98.14
  • 50 Day
  • ₹100.44
  • 100 Day
  • ₹103.20
  • 200 Day
  • ₹106.40

Mangalam Drugs And Organics Resistance and Support

PIVOT
₹99.17
Resistance
First Resistance 102.33
Second Resistance 105.17
Third Resistance 108.33
RSI 52.54
MFI 45.53
MACD Single Line -1.15
MACD -0.94
Support
First Resistance 96.33
Second Resistance 93.17
Third Resistance 90.33

Mangalam Drugs And Organics Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 192,410 10,778,808 56.02
Week 75,994 4,181,190 55.02
1 Month 59,954 3,319,059 55.36
6 Month 72,743 3,324,355 45.7

Mangalam Drugs And Organics Result Highlights

Mangalam Drugs and Organics Synopsis

NSE-Medical-Generic Drugs

Mangalam Drugs is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 372.25 Cr. and Equity Capital is Rs. 15.83 Cr. for the Year ended 31/03/2023. Mangalam Drugs and Organics Ltd. is a Public Limited Listed company incorporated on 18/04/1972 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1972PLC116413 and registration number is 116413.
Market Cap 158
Sales 323
Shares in Float 0.79
No of funds 4
Yield 0.68
Book Value 1.01
U/D Vol ratio 1.3
LTDebt / Equity 12
Alpha -0.16
Beta 0.41

Mangalam Drugs and Organics

Owner NameSep-23Jun-23Mar-23Dec-22
Promoters 50.32%50.32%50.32%50.32%
Foreign Portfolio Investors 0.1%0.1%0.1%0.1%
Financial Institutions/ Banks
Individual Investors 44.55%44.64%44.22%44.27%
Others 5.03%4.94%5.36%5.31%

Mangalam Drugs and Organics Management

Name Designation
Mr. Govardhan M Dhoot Chairman & Managing Director
Mr. Brijmohan M Dhoot Whole Time Director
Mr. Rakesh K Milwani Non Exe.Non Ind.Director
Mr. Rukmesh P Dhandhania Independent Director
Mrs. Nidhi S Mundada Independent Director
Mr. Praveen Saxena Independent Director

Mangalam Drugs And Organics Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Mangalam Drugs And Organics Corporate Action

Date Purpose Remarks
2023-11-08 Quarterly Results
2023-08-10 Quarterly Results
2023-05-30 Audited Results
2023-02-13 Quarterly Results
2022-11-11 Quarterly Results

Mangalam Drugs and Organics FAQs

What is Share Price of Mangalam Drugs and Organics ?

Mangalam Drugs and Organics share price is ₹99 As on 07 December, 2023 | 02:47

What is the Market Cap of Mangalam Drugs and Organics ?

The Market Cap of Mangalam Drugs and Organics is ₹157.5 Cr As on 07 December, 2023 | 02:47

What is the P/E ratio of Mangalam Drugs and Organics ?

The P/E ratio of Mangalam Drugs and Organics is -9.2 As on 07 December, 2023 | 02:47

What is the PB ratio of Mangalam Drugs and Organics ?

The PB ratio of Mangalam Drugs and Organics is 1 As on 07 December, 2023 | 02:47

Q2FY23